Hepatitis C and blood transfusion among children attending the Sickle Cell Clinic at Mulago Hospital, Uganda

African Health Sciences

Volumn 13, Issue 2, 2013, Pages 255-260

  Namasopo, Sophie OM ^a   Ndugwa, C ^b   Tumwine, J K ^b  

^a Jinja Regional Referral Hospital   (Uganda)

^b MAKERERE UNIVERSITY   (Uganda)

Author keywords

Blood transfusion; Hepatitis C; Sickle cell

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD TRANSFUSION; CHILD; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SICKLE CELL ANEMIA; UGANDA; VIRUS IDENTIFICATION;

BLOOD TRANSFUSION; HEPATITIS C; SICKLE CELL;

ADOLESCENT; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; FEMALE; HEPACIVIRUS; HEPATITIS C; HOSPITALS, COMMUNITY; HUMANS; INFANT; MALE; ODDS RATIO; UGANDA;

EID: 84883717927     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v13i2.8     Document Type: Article

References (26)

1. Choo QL, Weiner AJ, Overby, et al. Hepatitis C Virus: the major causative agent of non-A, non-B hepatitis. Br Med Bull 1990:46:423-41
2. Bhattacharya DK, Bhattacharjee S, Lahiri P D. Prevalence of Hepatitis C in transfusion dependent haemophiliacs and thalassaemics. Ind J Med Res (B) 1991;94:430-2.
3. Al-Fawaz I, Ramia S. Decline in hepetitis B infection in sickle cell anaemia and B thalasseamia major. Arch dis child 1993;69:594-6.
4. Biggar RJ, Ortiz-Conde BA, Bagni RK, et al. Hepatitis C virus genotype 4 in Ugandan children and their mothers. Emerg Infect Dis. 2006 Sep;12 (9):1440-3.
5. Wolfgang H, Kataha P, Downing R, et al. Prevalence and testing costs for Hepatitis C (HCV) among Ugandan blood donors 1999 unpublished.
6. Segbena AY, Prince-David M, Kagone TS, Dagnra AY Human immunodeficiency virus, hepatitis C virus and hepatitis B viruses in patients with sickle-cell disease in Togo. Transfus Clin Biol. 2005 Dec;12(6):423-6. Epub 2006 Jan 18
7. Ray KW, Global epidemiology and burden of Hepatitis C. Microbes and infection 2002; 4: 1219-1225.
8. Farci P, Alter HJ, Govindarjan S, et al. Lack of protective immunity against reinfection with HCV. Science 1992: 258: 135-40
9. Berham RE, Kieigman RM, Jenson HJ: Viral Hepatitis. In Nelsons Textbook of Paediatrics. 16th Edition.2000 177:773-4.
10. Global surveillance and control of hepatitis C. Report of a WHO consultation organised in collaboration with the viral hepatitis prevention board, Antwerp Belgium. J viral Hepat, 1999,6, 35-47.
11. Anonymous, Hepatitis C, Wkly Epidemiol Rec. 1997; 72(10): 65-69.
12. Alter M J. Epidemiology of hepatitis C. Hepatology 1997; 26(suppl.1): 62-5s
13. Johnson CS, Coursaget P, Tong M, et al. Prevalence of Hepatitis C virus in Sickle cell disease. Blood 1990;76(Suppl 1): 64a. for high genetic diversity and long-term endemicity of hepatitis C virus genotype.
14. Jeannel D, Fretz C, Traore Y, et al. Evidence types 1 and 2 in West Africa. J. Med Virol 1998 Jun;55(2):92-7.
15. Ndumbe PM, Skalsky J. Hepatitis C virus infection in different populations in Cameroon. Scand J Infect Dis 1993;25(6):689-92.
16. Mutimer DJ, Olomu A, Skidmore, et al. Viral Hepatitis in Nigeria-Sickle cell disease and commercial blood donors. QJM 1994 Jul;87(7):407-11.
17. Richard S, Billet HH. Liver function tests in Sicklers. Clinical Lab Haematology 2002;24(1):21-7
18. King SD, Dodd RY, Haynes G, Serjeant GR, et al. Prevalence of antibodies tohepatitis C virus and other markers in Jamaica. West Indian Med J 1995;44(2)55-7
19. Adewuyi JO. Prevalence of antibodies to hepatitis C virus among normal blood donors and multitransfused sickle cell anaemia patients in Nigeria. Tropical Doctor 1996; 26:29-30
20. Kitundu J, Msengi A, Matee M, et al. Posttransfusion Hepatitis C sero-prevalence in Tanzanian children. Ann Trop paediatr 2001;21(4):343-8.
21. Madhava V, Burgress C, Drucker E. Epidemiology of chronic HCV infection sub-Sahara Africa. Lancet Infect Dis. 2002; 2(5):293-302.
22. Kish and Lesleie, Survey Sampling New York. Wiley and sons, 1965; 49-50
23. From the manufacturers protocol enclosed in the Kit for IMX HCV Version 3.0 2002. ABBOTT Diagnostics.
24. Jackson JB, Guay L, Goldfarb J et al. Hepatitis C virus anti-body in HIV-1 infected Ugandan mothers. Lancet 1991; 337: 551.
25. Epodoi J. laboratory predictors of cholelithiasis in patients with Sickle cell disease. Dissertation M. Med Surgery 2001.
26. Mbulaiteye SM, Biggar RJ, Ndugwa CM, et al. Human Herpes virus 8 infection and transfusion history in children with sickle cell disease in Uganda. Journal of the National Cancer Institute, 2003; 95: 1330-1335.